financetom
Business
financetom
/
Business
/
Update: Market Chatter: Moderna Wins Patent Ruling Against Pfizer, BioNTech in German Court
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Market Chatter: Moderna Wins Patent Ruling Against Pfizer, BioNTech in German Court
Mar 6, 2025 11:34 AM

02:28 PM EST, 03/06/2025 (MT Newswires) -- (Updates with Moderna ( MRNA ) and BioNTech's responses in the fifth and sixth paragraphs, along with the latest stock move in the last paragraph.)

Pfizer ( PFE ) and its partner BioNTech (BNTX) have infringed a COVID-19 vaccine patent owned by Moderna ( MRNA ) , Reuters reported Wednesday, citing a German court ruling.

The court reportedly ordered Pfizer ( PFE ) and BioNTech to disclose earnings related to the patent's use and pay a compensation to Moderna ( MRNA ), according to the report.

Pfizer ( PFE ) and BioNTech argued they were permitted to use the technology based on Moderna's ( MRNA ) public statement until the World Health Organization declared in May 2023 that COVID-19 was no longer a global emergency, the media outlet reported.

The court did not determine the compensation amount, which will be decided in further legal proceedings and could change if there is an appeal, Reuters said.

A Moderna ( MRNA ) spokesperson told MT Newswires that the company is "pleased with the Court's decision," adding that the company will continue to pursue intellectual property rights.

"It is important to note that an appeal to the European Patent Office's Technical Board of Appeal regarding the ongoing opposition to this patent is pending," a BioNTech spokesperson told MT Newswires. "Today's decision has no immediate impact on Pfizer ( PFE ), BioNTech, or Comirnaty. We continue to believe that EP949 is invalid, and therefore not infringed, and will appeal the Dusseldorf District Court's decision on this patent."

Pfizer ( PFE ) did not immediately respond to requests for comment from MT Newswires.

Shares of Pfizer ( PFE ) were up about 1.5% in recent trading, while BioNTech and Moderna's ( MRNA ) stock was down 3% and 2.8%, respectively.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 26.35, Change: +0.41, Percent Change: +1.58

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Boeing re-captures Turkish airline Pegasus with MAX jet order
Boeing re-captures Turkish airline Pegasus with MAX jet order
Dec 20, 2024
* * Pegasus Airlines' 737 MAX order is worth nearly $6 billion after discounts, according to industry analyst * Boeing ( BA ) still working with FAA to certify 737 MAX 10 and MAX 7 * Pegasus will consider firm orders for 100 more jets based on market conditions in coming years (Adds Airbus shares in paragraph 4 and comment...
Liberty Broadband Insider Sold Shares Worth $12,812,972, According to a Recent SEC Filing
Liberty Broadband Insider Sold Shares Worth $12,812,972, According to a Recent SEC Filing
Dec 20, 2024
03:30 AM EST, 12/20/2024 (MT Newswires) -- Gregory B Maffei, 10% Owner, Director, President, Chief Executive Officer, on December 18, 2024, sold 161,733 shares in Liberty Broadband ( LBRDA ) for $12,812,972. Following the Form 4 filing with the SEC, Maffei has control over a total of 1,811,196 shares of the company, with 1,398,523 shares held directly and 412,673 controlled...
Boeing re-captures Turkish airline Pegasus with MAX jet order
Boeing re-captures Turkish airline Pegasus with MAX jet order
Dec 20, 2024
(Reuters) -Boeing has secured a firm order from Turkish low-cost carrier Pegasus Airlines for a hundred 737 MAX 10 jetliners, winning back a major customer from Airbus in a boost for the U.S. planemaker's largest single-aisle model. The order, which Boeing said on Thursday includes options for another 100, marks the biggest MAX order this year and caps a tumultuous...
Sprouts Farmers Market Insider Sold Shares Worth $1,576,286, According to a Recent SEC Filing
Sprouts Farmers Market Insider Sold Shares Worth $1,576,286, According to a Recent SEC Filing
Dec 20, 2024
03:29 AM EST, 12/20/2024 (MT Newswires) -- Jack Sinclair, Director, Chief Executive Officer, on December 17, 2024, sold 11,428 shares in Sprouts Farmers Market ( SFM ) for $1,576,286. Following the Form 4 filing with the SEC, Sinclair has control over a total of 152,434 shares of the company, with 152,434 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1575515/000157551524000188/xslF345X05/wk-form4_1734659142.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved